skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling

Journal Article · · Gastroenterology
ORCiD logo [1];  [2];  [3];  [4];  [1];  [1];  [1];  [5];  [1];  [6];  [7];  [8];  [1];  [3];  [1]
  1. Harvard Medical School, Boston, MA (United States)
  2. Shanghai Normal University (China); Harvard Medical School, Boston, MA (United States)
  3. Univ. of California, Los Angeles, CA (United States)
  4. Harvard Medical School, Boston, MA (United States); Sun Yat-sen University, Guangzhou (China)
  5. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States); USDOE Joint Genome Institute (JGI), Berkeley, CA (United States)
  6. Stony Brook University Hospital, Stony Brook, NY (United States)
  7. University of Arkansas for Medical Sciences, Little Rock, AR (United States)
  8. University of Massachusetts Medical School, Worcester, MA (United States)

Background & Aims: Clostridioides difficile toxin A (TcdA) activates the innate immune response. TcdA co-purifies with DNA. Toll-like receptor 9 (TLR9) recognizes bacterial DNA to initiate inflammation. We investigated whether DNA bound to TcdA activates an inflammatory response in murine models of C difficile infection via activation of TLR9. Methods: We performed studies with human colonocytes and monocytes and macrophages from wild-type and TLR9 knockout mice incubated with TcdA or its antagonist (ODN TTAGGG) or transduced with vectors encoding TLR9 or small-interfering RNAs. Cytokine production was measured with enzyme-linked immunosorbent assay. We studied a transduction domain of TcdA (TcdA57-80), which was predicted by machine learning to have cell-penetrating activity and confirmed by synchrotron small-angle X-ray scattering. Intestines of CD1 mice, C57BL6J mice, and mice that express a form of TLR9 that is not activated by CpG DNA were injected with TcdA, TLR9 antagonist, or both. Enterotoxicity was estimated based on loop weight to length ratios. A TLR9 antagonist was tested in mice infected with C difficile. We incubated human colon explants with an antagonist of TLR9 and measured TcdA-induced production of cytokines. Results: The TcdA57-80 protein transduction domain had membrane remodeling activity that allowed TcdA to enter endosomes. TcdA-bound DNA entered human colonocytes. TLR9 was required for production of cytokines by cultured cells and in human colon explants incubated with TcdA. TLR9 was required in TcdA-induced mice intestinal secretions and in the survival of mice infected by C difficile. Even in a protease-rich environment, in which only fragments of TcdA exist, the TcdA57-80 domain organized DNA into a geometrically ordered structure that activated TLR9. Conclusions: TcdA from C difficile can bind and organize bacterial DNA to activate TLR9. TcdA and TcdA fragments remodel membranes, which allows them to access endosomes and present bacterial DNA to and activate TLR9. Rather than inactivating the ability of DNA to bind TLR9, TcdA appears to chaperone and organize DNA into an inflammatory, spatially periodic structure.

Research Organization:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States); SLAC National Accelerator Lab., Menlo Park, CA (United States). Stanford Synchrotron Radiation Lightsource (SSRL)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER); Crohn's & Colitis Foundation of America; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); National Science Foundation (NSF); USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institute of General Medical Sciences (NIGMS)
Grant/Contract Number:
AC02-05CH11231; AC02-76SF00515
OSTI ID:
1844371
Alternate ID(s):
OSTI ID: 1734382
Journal Information:
Gastroenterology, Vol. 159, Issue 6; ISSN 0016-5085
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (52)

Glucosylation of Rho proteins by Clostridium difficile toxin B journal June 1995
Identification of an Essential Region for Translocation of Clostridium difficile Toxin B journal August 2016
Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome journal June 2014
A Mouse Model of Clostridium difficile–Associated Disease journal December 2008
Defective mutations within the translocation domain of Clostridium difficile toxin B impair disease pathogenesis journal October 2015
TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation journal February 2011
The C. difficile toxin B membrane translocation machinery is an evolutionarily conserved protein delivery apparatus journal January 2020
Clostridium difficile Toxin–Induced Inflammation and Intestinal Injury Are Mediated by the Inflammasome journal August 2010
Clostridium difficile infection: Toxins and non-toxin virulence factors, and their contributions to disease establishment and host response journal March 2012
Molecular Motor Dnm1 Synergistically Induces Membrane Curvature To Facilitate Mitochondrial Fission journal November 2017
Intrinsic Toxin-Derived Peptides Destabilize and Inactivate Clostridium difficile TcdB journal July 2017
Clostridium difficile — More Difficult Than Ever journal October 2008
Mapping membrane activity in undiscovered peptide sequence space using machine learning journal November 2016
Binding and entry of Clostridium difficile toxin B is mediated by multiple domains journal November 2015
Purification and characterization of toxins A and B of Clostridium difficile journal March 1982
Control of infection by pyroptosis and autophagy: role of TLR and NLR journal March 2010
Toxin Binding of Tolevamer, a Polyanionic Drug that Protects against Antibiotic-Associated Diarrhea journal July 2004
Cell-penetrating peptides derived from Clostridium difficile TcdB2 and a related large clostridial toxin journal February 2018
Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling journal April 2011
Nika : software for two-dimensional data reduction journal March 2012
Antimicrobial peptides and induced membrane curvature: Geometry, coordination chemistry, and molecular engineering journal August 2013
Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells journal June 2019
Cholesterol-dependent Pore Formation of Clostridium difficile Toxin A journal March 2006
Overview of Clostridium difficile infection: implications for China journal November 2013
Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 journal January 2007
Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9 journal April 2017
Identification of a conserved membrane localization domain within numerous large bacterial protein toxins journal March 2010
Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins journal August 2011
Clostridium difficile Infection: A Worldwide Disease journal January 2014
Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death journal May 2019
Liquid-crystalline ordering of antimicrobial peptide–DNA complexes controls TLR9 activation journal June 2015
Gut inflammation provides a respiratory electron acceptor for Salmonella journal September 2010
Proteases and the gut barrier journal March 2012
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis journal May 2019
Spore Formation and Toxin Production in Clostridium difficile Biofilms journal January 2014
Mechanisms of Disease: protease functions in intestinal mucosal pathobiology journal July 2007
Clostridium difficile Toxins: Mechanism of Action and Role in Disease journal April 2005
Identification of an N-Terminal Recognition Site in TLR9 That Contributes to CpG-DNA-Mediated Receptor Activation journal June 2009
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens journal September 2013
Crystallinity of Double-Stranded RNA-Antimicrobial Peptide Complexes Modulates Toll-Like Receptor 3-Mediated Inflammation journal October 2016
The host immune response to Clostridium difficile journal August 2011
Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria journal February 2011
Cytotoxicity of Clostridium difficile toxins A and B requires an active and functional SREBP‐2 pathway journal December 2018
Structure and mode of action of clostridial glucosylating toxins: the ABCD model journal May 2008
Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions journal October 2011
Bacterial Toxin Effector-Membrane Targeting: Outside in, then Back Again journal January 2012
Helical antimicrobial peptides assemble into protofibril scaffolds that present ordered dsDNA to TLR9 journal March 2019
TLR9 as a key receptor for the recognition of DNA☆ journal April 2008
Regulation of Apoptosis and Innate Immune Stimuli in Inflammation-Induced Preterm Labor journal October 2013
Low pH-induced Formation of Ion Channels by Clostridium difficile Toxin B in Target Cells journal January 2001
Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore journal February 2014
p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis journal April 2000